All In Biotech

Free tool

FAERS Monitor: Octreoscan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020314 or its brand name (Octreoscan, Indium In-111 Pentetreotide Kit). Reports on generic versions are filed under their own applications.

Reports

128

Serious

87

68% of reports

Hospitalization

23

Death reported

42

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • intentional drug misuse31
  • death21
  • haemoglobin abnormal16
  • nausea15
  • drug ineffective14
  • platelet disorder10
  • product use issue10
  • disease progression8
  • product use in unapproved indication8
  • blood bilirubin abnormal7
  • haematotoxicity7
  • pyrexia7
  • diarrhoea6
  • flushing6
  • malignant neoplasm progression6

Reports by year received

View as table
YearReports
20071
20085
200917
201037
20113
20124
20145
20156
20165
20175
20188
20191
202021
20212
20222
20232
20244

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,031 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood bilirubin abnormalSignal7903.8438.95,412
platelet disorderSignal10654.3360.45,863
haemoglobin abnormalSignal16409.7258.96,108
intentional drug misuseSignal31244.0179.57,257
haematotoxicitySignal7121.158.9718
disease progressionSignal811.15.764
flushingSignal69.74.439
malignant neoplasm progressionSignal69.64.438
product use issueSignal108.74.862
product use in unapproved indicationSignal85.32.724
deathSignal214.02.746
pyrexiaSignal73.31.69
nauseaSignal153.11.920
drug ineffective141.71.14
diarrhoea61.50.71

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.